Cell Prothera: assist cardiac muscle to auto-regenerate following a myocardial infarction | CNIM It will soon be possible to assist cardiac muscle to auto-regenerate following a myocardial infarction. This is the objective of CellProthera, which, with the help of Bertin Technologies, a CNIM Group company, has developed a unique and proprietary therapeutic concept of tissue and vascular repair of the myocardium. A glimmer of hope for the 120,000 victims of a myocardial infarction every year in France. Regenerating the heart after a severe infarction The start-up CellProthera has developed a treatment consisting of autologous progenitor cells obtained from a simple blood sample taken from the patient after myocardial infarction. Multiplied in vitro, they create a cellular graft, which

Join for free to read